PharmaPath specializes in the development, supply and life-cycle management of high-quality generic solid oral dosage pharmaceutical products. Founded in 2017, the company has since established a strong presence in the global pharmaceutical market, exporting to more than 45 countries, with products reaching over 120 markets worldwide.

Our manufacturing site, located in Athens, Greece, is a 6.400 sqm facility, with continuous investment in state-of-the-art technology. It is certified by the Greek and European regulatory authorities, as well as by several international agencies, including those in Brazil, Russia, the Middle East and Australia.

Our site manufactures solid oral dosage forms and offers the following services:

• Out-licensing and supply

• Contract manufacturing

• Analytical services

• Quality and compliance services

PharmaPath continues to invest dynamically in the pharmaceutical sector, steadily expanding its workforce and broadening its export footprint by partnering with new clients across emerging global markets.

The passion, dedication, reliability and strong business ethics of the entire PharmaPath team drive the company’s commitment to building long-term, value-driven partnerships — united by a shared purpose: safeguarding and advancing human health.